Dermacell AWM® is an advanced human acellular dermal matrix (ADM) engineered for complex wound care and surgical reconstruction.1 Trusted globally and now available in India, it delivers the safety, convenience, and clinical performance surgeons need to support healing — even in wounds with exposed tendon or bone.4
See how Dermacell AWM® delivers meaningful results for challenging wounds in real-world clinical settings.
Dermacell AWM® retains essential ECM components that are vital for tissue repair and wound healing, and preserves biomechanical integrity for reliable surgical use, maintaining tensile strength and suture pull-out performance comparable to fresh dermis.2,3,5,6
Mimics native human skin to support natural healing.2,3,5,6
biomechanical integrity for durable tissue support.2
Accelerates healing and reduces risk of amputation.7
No rehydration or refrigeration needed— use straight from the package. 1
Dermacell AWM is designed for a wide range of applications from chronic wounds and traumatic injuries to complex surgical reconstruction.1
- Diabetic foot ulcer
- Venous leg ulcer
- Pressure injury
- Traumatic injury
- Burns
- Dehiscence
- Craniomaxillofacial
- Chronic scalp wound
- Mohs procedure
| DESCRIPTION | THICKNESS | SIZE | SHELF LIFE | ORDER CODE |
|---|---|---|---|---|
Unmeshed Room Temperature Ready-to-use (15°C to 30°C) | 0.2 - 1.00 mm | 2x2 cm | 1.5 years | DCELL100 |
4×4 cm | 3 years | DCELL101 | ||
5x7 cm | 3 years | DCELL102 | ||
6x7 cm | 3 years | DCELL103 | ||
4x8 cm | 3 years | DCELL104 | ||
Meshed Meshed at a 1.5:1 ratio Room Temperature Ready-to-use (15°C to 30°C) | 2x2 cm | 1.5 years | DCELL110 | |
3×3 cm | 3 years | DCELL111 | ||
4×4 cm | 3 years | DCELL112 | ||
5x7 cm | 3 years | DCELL152 | ||
6x7 cm | 3 years | DCELL153 | ||
4x8 cm | 3 years | DCELL154 | ||
5x9 cm | 3 years | DCELL155 |
Dermacell AWM is powered by Matracell®, a proprietary decellularization process that enhances both the safety and efficacy of allograft tissues. Matracell removes the vast majority of donor DNA while preserving the extracellular matrix (ECM) — reducing immune response and promoting optimal cell attachment, migration, and vascularization. 2,3,5,6,11
Note: Inherent methodological variation between studies may affect the precision of comparisons.
- Data on file at LifeNet Health. Dermacell AWM Instructions for Use, 63-0050-09.
- Moore MA, Samsell B, Wallis G, et al. Decellularization of human dermis using non-denaturing anionic detergent and endonuclease: a review. Cell Tissue Bank. 2015; 16(2):249-259. https://doi.org/10.1007/s10561-014-9467-4 (view)
- Agrawal H, Tholpady SS, Capito AE, Drake DB, Katz AJ. Macrophage phenotypes correspond with remodeling outcomes of various acellular dermal matrices. Open Journal of Regenerative Medicine. 2012; 01(03):51-59. https://doi.org/10.4236/ojrm.2012.13008 (view)
- Cazzell S, Moyer PM, Samsell B, Dorsch K, McLean J, Moore MA. A Prospective, Multicenter, Single-Arm Clinical Trial for Treatment of Complex Diabetic Foot Ulcers with Deep Exposure Using Acellular Dermal Matrix. Adv Skin Wound Care. 2019 Sep;32(9):409-415. doi: 10.1097/01.ASW.0000569132.38449.c0. PMID: 31361269; PMCID: PMC7328871. (view)
- 68-20-047, Analysis of the Acellular Matrix, Growth Factors, and Cytokines Present in Oracell.
- LifeNet Health, TR 0292, LifeNet Health’s Decellularized Dermis, Dermacell, Comparison to the USP Monograph, Scaffold Human Dermis.
- Cazzell, S., Vayser, D., Pham H., et al. A randomized clinical trial of a human acellular dermal matrix demonstrated superior healing rates for chronic diabetic foot ulcers over conventional care and an active acellular dermal matrix comparator. Wound Repair and Regeneration. 2017. (view)
- Naveed Ahmed Sheen, Ali Murtaza Samar, Muhammad Ibrar Butt, Zeeshan Ayub, and Faisal Nadeem, “Efficacy of Negative Pressure Wound Therapy in Early Diabetic Foot Ulcer Management in Comparison with Advanced Moist Wound Therapy,” Combined Military Hospital Sibi/National University of Medical Sciences Pakistan; Salisbury District Hospital, UK; Islam Teaching Hospital, Sialkot; Combined Military Hospital Quetta/National University of Medical Sciences Pakistan; Frontier Corps Hospital, Chitral. Pafmj. 2021; 71(6):2087-2090. https://doi.org/10.51253/pafmj.v6i6.6231 (view)
- Blume PA, Walters J, Payne W, Ayala J, Lantis J. Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial. Diabetes Care. 2008; 31(4):631-636. https://doi.org/10.2337/dc07-2196 (view)
- Chen SG, Tzeng YS, Wang CH. Treatment of severe burn with DermACELL®, an acellular dermal matrix. Int J Burns Trauma. 2012; 2(2): 105-109 (view)
- Capito AE, Tholpady SS, Agrawal H, Drake DB, Katz AJ. Evaluation of host tissue integration, revascularization, and cellular infiltration within various dermal substrates. Ann Plast Surg. 2012 May;68(5):495-500. doi: 10.1097/SAP.0b013e31823b6b01. PMID: 22531405. (view)